Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling

Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling

Bone morphogenetic protein receptor type 2 (BMPR2) mutations are present in patients with heritable and idiopathic pulmonary arterial hypertension (PAH). Circulating levels of interleukin-1 (IL-1) are raised in patients and animal models. Whether interplay between BMP and IL-1 signaling can explain...

Full description

Bibliographic Details
Main Authors:	Josephine Pickworth, Alexander Rothman, James Iremonger, Helen Casbolt, Kay Hopkinson, Peter M. Hickey, Santhi Gladson, Sheila Shay, Nicholas W. Morrell, Sheila E. Francis, James D. West, Allan Lawrie
Format:	Article
Language:	English
Published:	Wiley 2017-09-01
Series:	Pulmonary Circulation
Online Access:	https://doi.org/10.1177/2045893217729096

Similar Items

Adverse effects of BMPR2 suppression in macrophages in animal models of pulmonary hypertension
by: James West, et al.
Published: (2020-03-01)

TRAIL Deficient Mice Are Protected from Sugen/Hypoxia Induced Pulmonary Arterial Hypertension
by: Sarah H. Dawson, et al.
Published: (2014-07-01)

BMPR2 expression is suppressed by signaling through the estrogen receptor
by: Austin Eric D, et al.
Published: (2012-02-01)

rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling
by: Anandharajan Rathinasabapathy, et al.
Published: (2018-04-01)

Selective improvement of pulmonary arterial hypertension with a dual ET/ET receptors antagonist in the apolipoprotein E model of PAH and atherosclerosis
by: Lewis Renshall, et al.
Published: (2018-01-01)

Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
by: Tatyana Novoyatleva, et al.
Published: (2021-08-01)

A potential adverse role for leptin and cardiac leptin receptor in the right ventricle in pulmonary arterial hypertension: effect of metformin is BMPR2 mutation-specific
by: Megha Talati, et al.
Published: (2023-10-01)

Overexpression of Msx1 in Mouse Lung Leads to Loss of Pulmonary Vessels Following Vascular Hypoxic Injury
by: James West, et al.
Published: (2021-09-01)

Copy-number variation in <it>BMPR2 </it>is not associated with the pathogenesis of pulmonary arterial hypertension
by: Cogan Joy D, et al.
Published: (2009-06-01)

Molecular and functional characterization of the BMPR2 gene in Pulmonary Arterial Hypertension
by: Guillermo Pousada, et al.
Published: (2017-05-01)

Homozygous missense variant in BMPR1A resulting in BMPR signaling disruption and syndromic features
by: Bianca E. Russell, et al.
Published: (2019-11-01)

Is iron deficiency caused by BMPR2 mutations or dysfunction in pulmonary arterial hypertension patients?
by: Vivienne Theobald, et al.
Published: (2023-04-01)

Bmpr2 mutant mice are an inadequate model for studying iron deficiency in pulmonary hypertension
by: Vida Zhang, et al.
Published: (2022-10-01)

A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach
by: Niamh Errington, et al.
Published: (2021-07-01)

A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension
by: Nadine D. Arnold, et al.
Published: (2019-11-01)

Chronic allergic inflammation causes vascular remodeling and pulmonary hypertension in BMPR2 hypomorph and wild-type mice.
by: Elizabeth M Mushaben, et al.
Published: (2012-01-01)

NF-κB Activation Exacerbates, but Is not Required for Murine Bmpr2-Related Pulmonary Hypertension
by: Megha Talati, et al.
Published: (2014-05-01)

PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension
by: Md Khadem Ali, et al.
Published: (2023-01-01)

Modification of hemodynamic and immune responses to exposure with a weak antigen by the expression of a hypomorphic BMPR2 gene.
by: Sung-Hyun Park, et al.
Published: (2013-01-01)

Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.
by: James D West, et al.
Published: (2016-01-01)

BMP7-based peptide agonists of BMPR1A protect the left ventricle against pathological remodeling induced by pressure overload
by: Ana B. Salido-Medina, et al.
Published: (2022-05-01)

Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension
by: Anandharajan Rathinasabapathy, et al.
Published: (2020-09-01)

Novel Advances in Modifying BMPR2 Signaling in PAH
by: Svenja Dannewitz Prosseda, et al.
Published: (2020-12-01)

Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
by: Mario Boehm, et al.
Published: (2018-03-01)

BMPR2 Editing in Fibroblast NIH3T3 using CRISPR/Cas9 Affecting BMPR2 mRNA Expression and Proliferation
by: Nugrahaningsih, Dwi Aris Agung, et al.
Published: (2022)

BMPR2 Editing in Fibroblast NIH3T3 using CRISPR/Cas9 Affecting BMPR2 mRNA Expression and Proliferation
by: Dwi Aris Agung Nugrahaningsih, et al.
Published: (2022-03-01)

Pulmonary Vascular Platform Models the Effects of Flow and Pressure on Endothelial Dysfunction in BMPR2 Associated Pulmonary Arterial Hypertension
by: Reid W. D’Amico, et al.
Published: (2018-08-01)

Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
by: Mario Boehm, et al.
Published: (2022-07-01)

BMP7 Signaling via BMPR1A, BMPR1B Inhibits the Proliferation of Lung Large Carcinoma NCI-H460 Cell
by: Huihui XU, et al.
Published: (2010-07-01)

<i>BMPR2</i> Variants Underlie Nonsyndromic Oligodontia
by: Jinglei Zheng, et al.
Published: (2023-01-01)

Investigating the Polymorphism of Bone Morphogenetic Protein Receptor-1B (<i>BMPR1B</i>) Gene in Markhoz Goat Breed
by: Sheila Pourali Dogaheh, et al.
Published: (2020-09-01)

A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension
by: Arnold, ND, et al.
Published: (2019)

Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers
by: Athénaïs Boucly, et al.
Published: (2022-01-01)

Truncating and missense <it>BMPR2 </it>mutations differentially affect the severity of heritable pulmonary arterial hypertension
by: Wheeler Lisa A, et al.
Published: (2009-09-01)

Analyses with double knockouts of the Bmpr1a and Bmpr1b genes demonstrate that BMP signaling is involved in the formation of precerebellar mossy fiber nuclei derived from the rhombic lip.
by: Lihua Qin, et al.
Published: (2019-01-01)

ACE2 trials suggest remodeling, not dilation, as primary therapeutic effect
by: James West
Published: (2022-01-01)

BMP2/BMPR1A is linked to tumour progression in dedifferentiated liposarcomas
by: Hannah L. O’Neill, et al.
Published: (2016-04-01)

Functional changes in pulmonary arterial endothelial cells associated with BMPR2 mutations.
by: Hu Wang, et al.
Published: (2014-01-01)

Mga Modulates Bmpr1a Activity by Antagonizing Bs69 in Zebrafish
by: Xiaoyun Sun, et al.
Published: (2018-09-01)

15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation
by: Kyung Jin Ahn, et al.
Published: (2019-10-01)